{
  "id": "CD012532.PUB2",
  "draft": "# Are anti-PD-1 and anti-PD-L1 therapies (which help the immune system fight cancer) effective for treating glioma (a type of brain tumor)?\n**Key Messages**\n- Anti-PD-1 and anti-PD-L1 therapies (which help the immune system fight cancer) may not be effective for treating glioma (a type of brain tumor), with most studies showing no benefit in overall survival (the length of time a person is alive after diagnosis or treatment) or progression-free survival (the length of time during and after treatment that a person lives with the disease but it does not get worse), although the quality of evidence is not strong enough to be certain.\n- The evidence for the effectiveness of these therapies in treating glioma is generally of low quality, and more research is needed to fully understand their potential benefits and harms, particularly in different subgroups of people with glioma, such as those with newly diagnosed or recurrent glioma.\n- Future studies should aim to provide higher-quality evidence and address the uncertainties surrounding the use of anti-PD-1 and anti-PD-L1 therapies for glioma, including their effects on quality of life (a person's overall sense of well-being, including their physical, emotional, and social health) and serious unwanted effects (harmful or unpleasant side effects of a treatment).\n**Introduction**\n### What is glioblastoma multiforme and why is it a problem?\nGlioblastoma multiforme (GBM) is the most common and aggressive type of adult glioma, a kind of brain tumor. It has a poor prognosis, with a median survival of only 16 months. The tumor's environment suppresses the immune system, making it hard for the body to fight the cancer. Current treatments have limited effectiveness, and new approaches are needed to improve patient outcomes.\n### What are immune checkpoint inhibitors and how do they work?\nImmune checkpoint inhibitors (ICIs) are a type of cancer treatment that helps the immune system recognize and attack cancer cells. They work by blocking specific proteins, such as PD-1 and PD-L1, that cancer cells use to evade the immune system. By blocking these proteins, ICIs allow the immune system to target and destroy cancer cells more effectively.\n### What did the review authors want to find out?\nThe review authors wanted to assess the effects of ICIs, specifically anti-PD-1 and anti-PD-L1 antibodies, in treating adults with diffuse glioma. They aimed to determine whether these treatments can improve overall survival, progression-free survival, and quality of life, while also examining their potential side effects.\n**Methods**\n### Methods\nWe searched for studies comparing anti-PD-1 and anti-PD-L1 antibodies to other treatments in adults with diffuse glioma, summarized their results, and rated our confidence in the evidence.\n**Results**\n### What did we find?\nWe found 7 studies that involved 1953 people with diffuse glioma. The biggest study was in 716 people and the smallest study was in 35 people. Most studies evaluated anti-PD-1 treatment in recurrent and newly diagnosed grade 4 glioma participants. The studies compared anti-PD-1/PD-L1 antibodies to placebo or other therapies used alone or with other ICIs. The population characteristics, study settings, and funding sources were not explicitly reported in the abstract. The types of interventions and comparisons varied across studies, including nivolumab versus bevacizumab, nivolumab plus bevacizumab, pembrolizumab plus bevacizumab, and nivolumab plus radiotherapy. The review found that nivolumab alone probably has no benefit in treating recurrent glioblastoma multiforme. Anti-PD1 plus bevacizumab may also be ineffective. Neoadjuvant plus adjuvant pembrolizumab may improve overall survival and progression-free survival, but this is based on very low-certainty evidence. In newly diagnosed glioblastoma multiforme, nivolumab plus radiotherapy probably has no benefit. Adjuvant nivolumab probably offers no benefit in older participants.\n**Limitations**\nThe evidence is limited by very small study sizes, possible lack of blinding (participants may have known their treatment), and incomplete reporting of outcomes of interest.\n**Currency**\nThe evidence is up to date to March 2024.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 706,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 30,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 23.533333333333335,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 11,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 58,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 28,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 17,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "nouns": {
          "value": 219,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 219.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 46.58209442870634,
          "rating": "P50",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 12.608396600566575,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 12.779216241737487,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 10.95966005665722,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 17.628630783758265,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 52.28687440982059,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 6.766666666666667,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 14.61895003862225,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 14.6 to <12.1 (median)"
        },
        "dale_chall_readability": {
          "value": 7.765057865911238,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 295,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 295.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 145,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 145.0 to <84.0 (median)"
        },
        "long_words": {
          "value": 203,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 203.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 706,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 706 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 1,
        "P50_count": 7,
        "P75_count": 5,
        "P90_count": 3,
        "P10_count": 0,
        "BEYOND_P90_count": 2,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 5.555555555555555,
        "P50_percentage": 38.88888888888889,
        "P75_percentage": 27.77777777777778,
        "P90_percentage": 16.666666666666664,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 11.11111111111111,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 33.33333333333333,
        "overall_assessment": "GOOD CONFORMITY WITH PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "The draft requires revision to meet Cochrane Plain Language Summary guidelines. Several subheadings are not phrased as questions, which is a critical formatting requirement. Additionally, the text contains overly long and complex sentences, uses noun-heavy phrasing, and includes some technical terms that could be simplified or better explained for a patient audience. These issues significantly impact readability and clarity.",
      "pls_evaluation_summary": "The linguistic analysis indicates good conformity with typical PLS patterns for several metrics, including Coleman-Liau Index, Flesch Reading Ease, and the balance of active and passive voice. However, the draft deviates significantly from typical PLS patterns in areas related to vocabulary complexity and noun usage. The 'nouns' count (219.0) is beyond the 90th percentile, suggesting a noun-heavy writing style. Similarly, 'complex_words_dc' (295.0) is beyond the 90th percentile, indicating a high number of unfamiliar words. 'Smog_index' (14.6), 'complex_words' (145.0), and 'long_words' (203.0) are all in the 90th percentile range, confirming that the text uses more complex and longer words than typical PLS. The 'words_per_sentence' metric (23.53) is in the 75th percentile, suggesting sentences are longer than ideal for a plain language summary. These deviations highlight areas where simplification of vocabulary and sentence structure would improve readability."
    }
  ]
}